ENALAPRIL - A REVIEW OF ITS PHARMACODYNAMIC AND PHARMACOKINETIC PROPERTIES, AND THERAPEUTIC USE IN HYPERTENSION AND CONGESTIVE-HEART-FAILURE

被引：325

作者：

TODD, PA

HEEL, RC

机构：

来源：

关键词：

D O I：

10.2165/00003495-198631030-00002

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

页码：198 / 248

页数：51

共 281 条

[1] Abrams WB, 1984, J HYPERTENS S2, V2, P31
[2] AJAYI AA, 1984, BRIT J CLIN PHARMACO, V17, pP607
[3] ANDREN L, 1983, J HYPERTENS S2, V1, P384
[4] ARR SM, 1985, BRIT J CLIN PHARMACO, V20, pP279
[5] ARR SM, 1984, BRIT J CLIN PHARMACO, V18, pP292
[6] NEW POTENT INHIBITORS OF ANGIOTENSIN CONVERTING ENZYME
ATTWOOD, MR
FRANCIS, RJ
HASSALL, CH
KROHN, A
LAWTON, G
NATOFF, IL
NIXON, JS
REDSHAW, S
THOMAS, WA
[J]. FEBS LETTERS, 1984, 165 (02) : 201 - 206
[7] BARNES JN, 1983, LANCET, V2, P41
[8] BAUER JH, 1983, CLIN RES, V31, pA246
[9] HEMODYNAMIC AND RENAL-FUNCTION IN ESSENTIAL-HYPERTENSION DURING TREATMENT WITH ENALAPRIL
BAUER, JH
REAMS, GP
[J]. AMERICAN JOURNAL OF MEDICINE, 1985, 79 (3C) : 10 - 13
[10] BAUER JH, 1984, CLIN RES, V32, pA328